Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001731122-20-000289
Filing Date
2020-03-23
Accepted
2020-03-23 08:00:37
Documents
1
Effectiveness Date
2020-03-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A e1821_defa14a.htm DEFA14A 11950
  Complete submission text file 0001731122-20-000289.txt   13097
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-37606 | Film No.: 20733625
SIC: 8731 Services-Commercial Physical & Biological Research